acting as RAF proto-oncogene serine/threonine-protein kinase (RAF-1; c-Raf) inhibitors reported to be useful for the treatment of cancer.
by the introduction of a new RAF form when issuing claims, without having followed the proper administrative channels. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback